Symptoms

Description: 
Presently, methadone is the recommended treatment for opioid-dependent pregnant women, but is associated with neonatal abstinence syndrome (NAS). NAS is characterized by opioid withdrawal symptoms in the newborn, which often requires longer hospitalization and treatment. Buprenorphine, FDA-approved in 2002 for the treatment of opioid dependence in non-pregnant individuals, hasn't been extensively studied during pregnancy. Yet, a new study in the New England Journal of Medicine (NEJM) found that buprenorphine offers an alternative to methadone in the treatment of opioid-dependent pregnant women. The study compared buprenorphine to methadone in 131 mothers and their newborns at eight international sites.
Source: 
New England Journal of Medicine
field_vote: 
Description: 
This article provides guidance on the treatment of alcohol and drug abuse, and discusses various treatment plans.
Source: 
National Institute on Drug Abuse (NIDA)
field_vote: 
Resource Type: 
Description: 
The ASI Self-Report Form asks questions about the following topics: your background and employment, your health and family relationships, your legal situation, and your drug and alcohol use.
Source: 
Center for Health Care Evaluation (CHCE)
field_vote: 
Resource Type: 
Description: 
This TIP, Substance Abuse Treatment for Persons With Co-Occurring Disorders, revises TIP 9, Assessment and Treatment of Patients With Coexisting Mental Illness and Alcohol and Other Drug Abuse. The revised TIP provides information about new developments in the rapidly growing field of co-occurring substance use and mental disorders and captures the state-of-the-art in the treatment of people with co-occurring disorders. The TIP focuses on what the substance abuse treatment clinician needs to know and provides that information in an accessible manner. The TIP synthesizes knowledge and grounds it in the practical realities of clinical cases and real situations so the reader will come away with increased knowledge, encouragement, and resourcefulness in working with clients with co-occurring disorders.
Source: 
U.S. Department of Health and Human Services, SAMHSA
field_vote: 
Resource Type: 
Description: 
Information on why your patient should be in withdrawal before beginning buprenorphine induction.
Source: 
Substance Abuse and Mental Health Services Administration (SAMHSA)
field_vote: 
Description: 
A description of the signs of opiate withdrawal useful for physicians in determining withdrawal during medically supervised detoxification.
Source: 
National Center for Biotechnology Information
field_vote: 
Physician stage in practice: 
Description: 
This article reviews the history of opiate withdrawal scales and their use.
Source: 
The Journal of Psychoactive Drugs
field_vote: 
Resource Type: 
Description: 
Provides patients with an in-depth look at what to expect from buprenorphine treatment including preparing for treatment, urine testing, counseling, and effects on sleep and relationships.
Source: 
The National Alliance of Advocates for Buprenorphine Treatment (NAABT)
field_vote: 
Physician stage in practice: 
Description: 
The prescribing information from the makers of Suboxone® including side effects, contraindications and drug interactions.
Source: 
Reckitt Benckiser
field_vote: 
Physician stage in practice: 
Description: 
This journal article (2006) discusses how to approach the treatment of acute pain in buprenorphine or methadone-maintained patients.
Source: 
Annals of Internal Medicine
field_vote: 
Physician stage in practice: 

Pages

Subscribe to Symptoms